Impact of COVID-19 on Hematologic Cancer Patients: Insights From the Late Pandemic Phase

被引：0

作者：

Caracciolo, Daniele ^{[1
,2
]}

D'Aquino, Giuseppe ^{[1
]}

Froio, Caterina ^{[1
]}

Romeo, Caterina ^{[1
]}

Bosco, Vincenzo ^{[3
]}

Pensabene, Giulia ^{[1
]}

Tedesco, Ludovica ^{[1
]}

Tagliaferri, Pierosandro ^{[1
,2
]}

Tassone, Pierfrancesco ^{[1
,2
]}

机构：

[1] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Campus Salvatore Venuta, Catanzaro, Italy

[2] AOU Renato Dulbecco, Med & Translat Oncol, Catanzaro, Italy

[3] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy

来源：

CANCER MEDICINE | 2025年 / 14卷 / 15期

关键词：

chronic lymphocytic leukemia; COVID-19; hematologic malignancies; late pandemic phase; multiple myeloma; myelodysplastic syndrome; non-Hodgkin lymphoma; MALIGNANCIES;

D O I：

10.1002/cam4.71112

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

BackgroundThe COVID-19 pandemic significantly increased mortality risks for individuals with hematological malignancies.Patients and MethodsWe conducted a single-center observational study, focusing on the late pandemic phase of the infection (2022-2023), to identify risk factors associated with COVID-19 outcomes in vaccinated patients with hematological malignancies.ResultsEighty-five COVID-19 cases were recorded among patients with hematological malignancies, primarily Multiple Myeloma (MM) (38.8%), chronic lymphocytic leukemia (CLL) (10.6%) and Non-Hodgkin Lymphoma (NHL) (35.3%). Despite a high COVID-19 vaccination rate (97.6%), severe/critical illness occurred in 23.5% of patients. The overall COVID-19-related mortality rate was 22.4%, with a 30-day mortality rate of 11.8%. Although mortality rates significantly decreased over the observation time (27.7% vs. 16.7%), this trend was not confirmed in critical infection carriers.ConclusionOur data confirm that, despite a reduction in critical infections and overall mortality rates over time, patients with hematological malignancies remain at high risk during the endemic phase of SARS-CoV-2 infection.

引用

页数：6

共 20 条

[1] Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers [J].

Basci, Semih ;

Ata, Naim ;

Altuntas, Fevzi ;

Yigenoglu, Tugce Nur ;

Dal, Mehmet Sinan ;

Korkmaz, Serdal ;

Namdaroglu, Sinem ;

Basturk, Abdulkadir ;

Hacibekiroglu, Tuba ;

Dogu, Mehmet Hilmi ;

Berber, Ilhami ;

Dal, Kursat ;

Erkurt, Mehmet Ali ;

Turgut, Burhan ;

Celik, Osman ;

Ulgu, Mustafa Mahir ;

Birinci, Suayip .

INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (01) :135-139

[2]

Evans Rachael A, 2023, Lancet Reg Health Eur, V35, P100747, DOI 10.1016/j.lanepe.2023.100747

[3] Severe acute respiratory syndrome coronavirus 2 infection in patients with hematological malignancies in the Omicron era: Respiratory failure, need for mechanical ventilation and mortality in seronegative and seropositive patients [J].

Franceschini, Erica ;

Menozzi, Valentina ;

Todisco, Vera ;

Pellegrino, Mariachiara ;

Cantergiani, Samuele ;

Dessilani, Andrea ;

Spadoni, Anna ;

Romani, Federico ;

Mazzocchi, Alice ;

Santoro, Antonella ;

Meschiari, Marianna ;

Cervo, Adriana ;

Gilioli, Andrea ;

Bettelli, Francesca ;

Fregni-Serpini, Giulia ;

Grottola, Antonella ;

Candoni, Anna ;

Guaraldi, Giovanni ;

Sarti, Mario ;

Luppi, Mario ;

Mussini, Cristina .

EJHAEM, 2024, 5 (03) :505-515

[4] Outcomes and Patterns of Evolution of Patients with Hematological Malignancies during the COVID-19 Pandemic: A Nationwide Study (2020-2022) [J].

Garcia-Carretero, Rafael ;

Ordonez-Garcia, Maria ;

Gil-Prieto, Ruth ;

Gil-de-Miguel, Angel .

JOURNAL OF CLINICAL MEDICINE, 2024, 13 (18)

[5] Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study [J].

Garcia-Suarez, Julio ;

de la Cruz, Javier ;

Cedillo, Angel ;

Llamas, Pilar ;

Duarte, Rafael ;

Jimenez-Yuste, Victor ;

Hernandez-Rivas, Jose Angel ;

Gil-Manso, Rodrigo ;

Kwon, Mi ;

Sanchez-Godoy, Pedro ;

Martinez-Barranco, Pilar ;

Colas-Lahuerta, Blanca ;

Herrera, Pilar ;

Benito-Parra, Laurentino ;

Alegre, Adrian ;

Velasco, Alberto ;

Matilla, Arturo ;

Alaez-Uson, Maria Concepcion ;

Martos-Martinez, Rafael ;

Martinez-Chamorro, Carmen ;

Susana-Quiroz, Keina ;

Del Campo, Juan Francisco ;

de la Fuente, Adolfo ;

Herraez, Regina ;

Pascual, Adriana ;

Gomez, Elvira ;

Perez-Oteyza, Jaime ;

Ruiz, Elena ;

Alonso, Arancha ;

Gonzalez-Medina, Jose ;

Martin-Buitrago, Lucia Nunez ;

Canales, Miguel ;

Gonzalez-Gascon, Isabel ;

Vicente-Ayuso, Maria Carmen ;

Valenciano, Susana ;

Roa, Maria Garcia ;

Monteliu, Pablo Estival ;

Lopez-Jimenez, Javier ;

Escobar, Cristian Escolano ;

Ortiz-Martin, Javier ;

Diez-Martin, Jose Luis ;

Martinez-Lopez, Joaquin .

JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)

[6] Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy [J].

Haque, Azizul ;

Pant, Anudeep B. .

JOURNAL OF AUTOIMMUNITY, 2022, 127

[7]

Harris Courtney E, 2023, Am Soc Clin Oncol Educ Book, V43, pe390778, DOI [10.1200/edbk_390778, 10.1200/EDBK_390778]

[8] Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside [J].

Laracy, Justin C. ;

Kamboj, Mini ;

Vardhana, Santosha A. .

CURRENT OPINION IN INFECTIOUS DISEASES, 2022, 35 (04) :271-279

[9] Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies [J].

Lee, Christina Y. ;

Shah, Monika K. ;

Hoyos, David ;

Solovyov, Alexander ;

Douglas, Melanie ;

Taur, Ying ;

Maslak, Peter ;

Babady, N. Esther ;

Greenbaum, Benjamin ;

Kamboj, Mini ;

Vardhana, Santosha A. .

CANCER DISCOVERY, 2022, 12 (01) :62-73

[10] COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study [J].

Lee, Lennard Y. W. ;

Cozier, Jean-Baptiste ;

Starkey, Thomas ;

Briggs, Sarah E. W. ;

Arnold, Roland ;

Bisht, Vartika ;

Booth, Stephen ;

Campton, Naomi A. ;

Cheng, Vinton W. T. ;

Collins, Graham ;

Curley, Helen M. ;

Earwaker, Philip ;

Fittall, Matthew W. ;

Gennatas, Spyridon ;

Goel, Anshita ;

Hartley, Simon ;

Hughes, Daniel J. ;

Kerr, David ;

Lee, Alvin J. X. ;

Lee, Rebecca J. ;

Lee, Siow Ming ;

Mckenzie, Hayley ;

Middleton, Chris P. ;

Murugaesu, Nirupa ;

Newsom-Davis, Tom ;

Olsson-Brown, Anna C. ;

Palles, Claire ;

Powles, Thomas ;

Protheroe, Emily A. ;

Purshouse, Karin ;

Sharma-Oates, Archana ;

Sivakumar, Shivan ;

Smith, Ashley J. ;

Topping, Oliver ;

Turnbull, Chris D. ;

Varnai, Csilla ;

Briggs, Adam D. M. ;

Middletont, Gary ;

Kerr, Rachel .

LANCET ONCOLOGY, 2020, 21 (10) :1309-1316

← 1 2 →